Effect of Intracameral Steroids During Phacoemulsification on the Cornea

Status Completed

Clinical Trial Summary

Prospective, interventional case control study. Sixty-nine eyes were randomized into 3 groups, 23 eyes each : 2groups received intracameral dexamethasone and triamcinolone (TA) respectively, while controls didn't receive any intraoperative steroids. Intracameral steroids at the conclusion of phacoemulsification significantly improved corneal edema and spared corneal endothelium.

Clinical Trial Description

Purpose: Investigating the effect of intracameral steroids at the end of phacoemulsification on corneal edema and endothelial count. Methods: Prospective, interventional case control study. Sixty-nine eyes were randomized into 3 groups, 23 eyes each : 2groups received intracameral dexamethasone and triamcinolone (TA) respectively, while controls didn't receive any intraoperative steroids. On the first postoperative day corneal edema in control compared to dexamethasone and TA groups respectively. One month later, the mean increase of corneal thickness in control compared to intracameral dexamethasone and TA groups, respectively. mean endothelial cell loss in control compared to intracameral dexamethasone and TA groups respectively. ;

Study Design

Related Conditions & MeSH terms

Corneal Edema

Clinical Trial Details

NCT number	NCT05271058
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	Phase 3
Start date	June 16, 2019
Completion date	August 15, 2020

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05139771` - EndoArt® Implantation in Subjects With Chronic Corneal Edema	N/A
Enrolling by invitation	`NCT05956535` - Air Optix® Night and Day® Aqua Therapeutic Wear
Completed	`NCT02332109` - ODM 5 in the Treatment of Corneal Edematous Fuchs' Endothelial Dystrophy	N/A
Completed	`NCT04498169` - A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy	Phase 2
Active, not recruiting	`NCT06041256` - A Phase 1/2 Study of AURN001 in Subjects With Corneal Edema Secondary to Corneal Endothelial Dysfunction (ABA-1)	Phase 1/Phase 2
Completed	`NCT04521140` - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery	Phase 4
Completed	`NCT05136443` - Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection	Phase 4
Completed	`NCT01998568` - The Intraocular Pressure Measured by Different Tonometers in Corneal Edema	N/A
Recruiting	`NCT04191629` - Phase 1 Study to Evaluate the Safety and Tolerability of EO1404 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT04975971` - A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
Completed	`NCT05309135` - A Safety and Efficacy Study of Corneal Injection for Endothelial Dysfunction Using Human Corneal Endothelial Cell Therapy in Subjects With Corneal Edema Secondary to Endothelial Dysfunction	Phase 1
Completed	`NCT01853696` - Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty	Phase 4
Completed	`NCT01244334` - Study of Difluprednate vs. Prednisolone Acetate on Visual Acuity, and Corneal Edema Following Cataract Surgery.	Phase 4
Completed	`NCT05891106` - AONDA Therapeutic Indication Study I
Active, not recruiting	`NCT04894110` - Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema	Phase 1
Completed	`NCT01387620` - Comparison of DisCoVisc and Hydroxypropylmethylcellulose 2%	Phase 4
Completed	`NCT00346138` - A Comparison Between Full Thickness and Partial Thickness Corneal Transplantation for Corneal Edema	N/A
Recruiting	`NCT05626478` - Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery	Phase 4
Completed	`NCT01890252` - Hyper-CL™ Lens (Hyper Osmotic Contact Lens) In Subjects Suffering From Corneal Edema	N/A
Not yet recruiting	`NCT00800423` - Effect of Topical Brimonidine on Post Cataract Surgery Corneal Edema	Phase 3